Gene · 2923
Papers3,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PDIA3 orchestrates effector T cell program by serving as a chaperone to facilitate the non-canonical nuclear import of STAT1 and PKM2. | Mol Ther | 2024 | 38822524 | PubTator, text mining | PubMed |
| Clinicopathological significance of protein disulphide isomerase A3 and phosphorylated signal transducer and activator of transcription 3 in cervical carcinoma. | Contemp Oncol (Pozn) | 2024 | 38800530 | PubTator, text mining | PubMed |
| Inclusive Pattern Generation Protocols to Decode Thiol-Mediated Uptake. | ACS Cent Sci | 2024 | 38799667 | PubTator, text mining | PubMed |
| Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation. | Proc Natl Acad Sci U S A | 2024 | 38771881 | PubTator, text mining | PubMed |
| PDIA3 driven STAT3/PD-1 signaling promotes M2 TAM polarization and aggravates colorectal cancer progression. | Aging (Albany NY) | 2024 | 38761176 | PubTator, text mining | PubMed |
| A Systematic Review of Proteomics in Obesity: Unpacking the Molecular Puzzle. | Curr Obes Rep | 2024 | 38703299 | PubTator, text mining | PubMed |
Endoplasmic reticulum stress produced by Thapsigargin affects the occurrence of spike-wave discharge by modulating unfolded protein response pathways and activating immune responses in a dose-dependent manner. | Eur J Pharmacol | 2024 | 38670446 | PubTator, text mining | PubMed |
| Hepatitis E virus ORF3 protein hijacking thioredoxin domain-containing protein 5 (TXNDC5) for its stability to promote viral particle release. | J Virol | 2024 | 38548704 | PubTator, text mining | PubMed |
| Cellular Organelle-Related Transcriptomic Profile Abnormalities in Neuronopathic Types of Mucopolysaccharidosis: A Comparison with Other Neurodegenerative Diseases. | Curr Issues Mol Biol | 2024 | 38534785 | PubTator, text mining | PubMed |
| Recent advances in vascular thiol isomerases and redox systems in platelet function and thrombosis. | J Thromb Haemost | 2024 | 38518897 | PubTator, text mining | PubMed |
| Long noncoding RNA protein-disulfide isomerase-associated 3 regulated high glucose-induced podocyte apoptosis in diabetic nephropathy through targeting miR-139-3p. | World J Diabetes | 2024 | 38464366 | PubTator, text mining | PubMed |
| Cellular responses to silencing of PDIA3 (protein disulphide-isomerase A3): Effects on proliferation, migration, and genes in control of active vitamin D. | J Steroid Biochem Mol Biol | 2024 | 38460707 | PubTator, text mining | PubMed |
| Inducing Melanoma Cell Apoptosis by ERp57/PDIA3 Antibody in the Presence of CPI-613 and Hydroxychloroquine. | J Cancer | 2024 | 38434963 | PubTator, text mining | PubMed |
| Downregulation of PDIA3 inhibits gastric cancer cell growth through cell cycle regulation. | Biomed Pharmacother | 2024 | 38412717 | PubTator, text mining | PubMed |
| A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels. | Blood | 2024 | 38320121 | PubTator, text mining | PubMed |
| Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy. | Cell Commun Signal | 2024 | 38297380 | PubTator, text mining | PubMed |
| Development and validation of an immunogenic cell death-related prognostic model, and landscape of the tumor immune microenvironment in glioblastoma. | Genes Dis | 2024 | 38274376 | PubTator, text mining | PubMed |
| Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer. | Sci Rep | 2024 | 38263419 | PubTator, text mining | PubMed |
| The Clinical Utility of the Saliva Proteome in Rare Diseases: A Pilot Study for Biomarker Discovery in Primary Sclerosing Cholangitis. | J Clin Med | 2024 | 38256678 | PubTator, text mining | PubMed |
| Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit. | Cancers (Basel) | 2024 | 38254801 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2923/papers?page=7